Bioavailability of Subcutaneously Given Dexmedetomidine in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Dexmedetomidine (Primary) ; Dexmedetomidine (Primary)
- Indications Cancer pain; Pain; Sedation
- Focus Pharmacokinetics
- Acronyms ScDex
- 19 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.
- 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Apr 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.